Metabolic syndrome is common in psoriatic arthritis and is a known risk factor for worse symptoms and poor treatment outcomes. This study sought to explore the syndrome's role in a more precisely ...

Deucravacitinib met its primary endpoint of more than 20% improvement in ACR20 response among patients with psoriatic ...

About one-third of psoriasis sufferers develop psoriatic arthritis, with swelling, tenderness and pain in joints, affecting daily activities and lifestyle. Psoriatic arthritis (PsA) is a chronic ...

Arthritis awareness emphasizes early detection of arthritis, a condition affecting joints, bones, and muscles. Recognizing ...

Dr. Michael Garshick discusses recently published recommendations for cardiovascular risk screening for patients with ...

About psoriatic arthritis. (2024). https: ... Singh J, et al. (2018). 2018 American College of Rheumatology/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis. https: ...

The causes and treatment options available vary from ... The fingers are most commonly affected with psoriatic arthritis (PsA), but this painful condition affects other joints as well.

APEX shows Tremfya is the first IL-23 inhibitor to slow joint damage in psoriatic arthritis, offering early, multi-domain ...

Some people with psoriatic arthritis report that eliminating dairy ... and following your prescribed treatment regimen are all important components of a well-rounded approach.

Celltrion's FDA approval of Steqeyma enhances pediatric psoriasis treatment, offering flexible dosing options for children ...

Applying ACV in diluted form to your skin may help relieve the redness and flakiness associated with psoriatic arthritis. ACV can help change the skin’s pH levels to lessen flaking, says Nicole ...

Phase 1 data for Spyre Therapeutics, Inc.'s SPY002 & SPY072 show promise in autoimmune treatments. Advancing to Phase 2 ...